T1	PROC 44 54	Prevención
#1	AnnotatorNotes T1	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T2	DISO 61 95	infección por el nuevo coronavirus
T3	CHEM 100 117	hidroxicloroquina
#2	AnnotatorNotes T3	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
T4	CHEM 169 186	HIDROXICLOROQUINA
#3	AnnotatorNotes T4	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
T5	PROC 267 320	ENSAYO CLÍNICO UNICÉNTRICO, DOBLE CIEGO, ALEATORIZADO
T6	DISO 343 373	Infección por coronavirus 2019
T7	DISO 764 768	VIH+
T8	PROC 454 463	serología
#4	AnnotatorNotes T8	C0036743; Serologic tests; Laboratory Procedure
T9	PROC 652 676	consentimiento informado
#5	AnnotatorNotes T9	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T10	PROC 569 585	test de embarazo
#6	AnnotatorNotes T10	C0032976; Pregnancy Tests; Diagnostic Procedure
T11	PROC 740 761	Tratamiento antiviral
#7	AnnotatorNotes T11	C2363964; Antiviral treatment; Therapeutic or Preventive Procedure
T12	PROC 771 799	Tratamiento antiinflamatorio
T13	PROC 802 813	Tratamiento
#8	AnnotatorNotes T13	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T14	CHEM 831 848	hidroxicloroquina
#9	AnnotatorNotes T14	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
T15	DISO 1252 1261	arritmias
#10	AnnotatorNotes T15	C0003811; Cardiac Arrhythmia; Disease or Syndrome
T16	PROC 952 976	consentimiento informado
#11	AnnotatorNotes T16	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T17	PROC 891 900	Serología
#12	AnnotatorNotes T17	C0036743; Serologic tests; Laboratory Procedure
T18	CHEM 1110 1127	hidroxicloroquina
#13	AnnotatorNotes T18	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
T19	DISO 1131 1148	Hipersensibilidad
#14	AnnotatorNotes T19	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T20	DISO 1151 1162	Retinopatía
#15	AnnotatorNotes T20	C0035309; Retinal Diseases; Disease or Syndrome
T21	DISO 1165 1186	alteraciones visuales
#16	AnnotatorNotes T21	C0547030; Visual disturbance; Finding | C3665347; Visual Impairment; Finding
T22	DISO 1189 1197	QT largo
#17	AnnotatorNotes T22	C0023976; Long QT Syndrome; Disease or Syndrome
T23	DISO 1199 1210	bradicardia
#18	AnnotatorNotes T23	C0428977; Bradycardia; Finding
T24	DISO 1221 1244	taquicardia ventricular
#19	AnnotatorNotes T24	C0042514; Tachycardia, Ventricular; Disease or Syndrome
T25	DISO 244 252	COVID-19
#20	AnnotatorNotes T25	C5203670; COVID19 (disease); Disease or Syndrome
T26	DISO 399 407	COVID-19
#21	AnnotatorNotes T26	C5203670; COVID19 (disease); Disease or Syndrome
T27	CHEM 1553 1563	macrolidos
#22	AnnotatorNotes T27	C0003240; Macrolide Antibiotics; Antibiotic · Organic Chemical | C0282563; Macrolides; Organic Chemical · Pharmacologic Substance
T28	DISO 1343 1359	Miastenia gravis
#23	AnnotatorNotes T28	C0026896; Myasthenia Gravis; Disease or Syndrome
T29	DISO 1362 1371	Psoriasis
#24	AnnotatorNotes T29	C0033860; Psoriasis; Disease or Syndrome
T30	DISO 1374 1382	porfiria
#25	AnnotatorNotes T30	C0032708; Disorders of Porphyrin Metabolism; Disease or Syndrome | C0235387; Porphyria type syndrome; Disease or Syndrome
T31	PROC 1385 1404	Filtrado glomerular
#26	AnnotatorNotes T31	C0017654; Glomerular Filtration Rate; Diagnostic Procedure
T32	CHEM 1565 1587	agalsidasa alfa y beta
#27	AnnotatorNotes T32	C0962517; agalsidase alfa; Amino Acid, Peptide, or Protein · Enzyme · Pharmacologic Substance + C1137427; agalsidase beta; Amino Acid, Peptide, or Protein · Enzyme · Pharmacologic Substance
T33	DISO 1430 1442	hipoglicemia
#28	AnnotatorNotes T33	C0020615; Hypoglycemia; Disease or Syndrome
T34	PROC 1452 1463	Tratamiento
#29	AnnotatorNotes T34	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T35	CHEM 1469 1482	antimaláricos
#30	AnnotatorNotes T35	C0003374; Antimalarials; Pharmacologic Substance
T36	CHEM 1484 1498	antiarrítmicos
#31	AnnotatorNotes T36	C0003195; Anti-Arrhythmia Agents; Pharmacologic Substance
T37	CHEM 1500 1526	antidepresivos triciclicos
#32	AnnotatorNotes T37	C0003290; Tricyclic Antidepressive Agents; Pharmacologic Substance
T38	CHEM 1528 1539	natalizumab
#33	AnnotatorNotes T38	C1172734; natalizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T39	CHEM 1541 1551	quinolonas
#34	AnnotatorNotes T39	C1533693; Quinolone Antibacterial Agents; Antibiotic · Organic Chemical
T40	PROC 139 149	PROFILAXIS
#35	AnnotatorNotes T40	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T41	PROC 448 451	PCR
#36	AnnotatorNotes T41	C0032520; Polymerase Chain Reaction; Molecular Biology Research Technique
T42	CHEM 752 761	antiviral
#37	AnnotatorNotes T42	C0003451; Antiviral Agents; Pharmacologic Substance
T43	CHEM 783 799	antiinflamatorio
#38	AnnotatorNotes T43	C0003209; Anti-Inflammatory Agents; Pharmacologic Substance
T44	CHEM 818 828	cloroquina
#39	AnnotatorNotes T44	C0008269; chloroquine; Organic Chemical · Pharmacologic Substance
T45	PROC 885 888	PCR
#40	AnnotatorNotes T45	C0032520; Polymerase Chain Reaction; Molecular Biology Research Technique
T46	ANAT 1233 1244	ventricular
#41	AnnotatorNotes T46	C0018827; Heart Ventricle; Body Part, Organ, or Organ Component | C1280934; Entire cardiac ventricle; Body Part, Organ, or Organ Component
T47	PROC 1266 1273	Potasio
#42	AnnotatorNotes T47	C0202194; Potassium measurement; Laboratory Procedure
T48	PROC 1286 1289	AST
#43	AnnotatorNotes T48	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T49	PROC 1293 1296	ALT
#44	AnnotatorNotes T49	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T50	DISO 1319 1339	infarto de miocardio
#45	AnnotatorNotes T50	C0027051; Myocardial infarction; Disease or Syndrome | C0155626; Acute myocardial infarction; Disease or Syndrome
T51	ANAT 1330 1339	miocardio
#46	AnnotatorNotes T51	C0027061; Myocardium; Tissue | C1284309; Entire myocardium; Tissue
T52	Date 12 16	2020
T53	LIVB 84 95	coronavirus
#47	AnnotatorNotes T53	C5203676; SARS-CoV-2; Virus
T54	LIVB 357 373	coronavirus 2019
#48	AnnotatorNotes T54	C5203676; SARS-CoV-2; Virus
T57	LIVB 542 549	Mujeres
#49	AnnotatorNotes T57	C0043210; Woman; Population Group
T58	Neg_cue 551 560	Negativas
T61	PHYS 717 725	Embarazo
#50	AnnotatorNotes T61	C0032961; Pregnancy; Organism Function
T62	PHYS 728 737	lactancia
#51	AnnotatorNotes T62	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T63	LIVB 870 880	SARS-CoV-2
#52	AnnotatorNotes T63	C5203676; SARS-CoV-2; Virus
T64	LIVB 915 925	SARS-CoV-2
#53	AnnotatorNotes T64	C5203676; SARS-CoV-2; Virus
T65	Neg_cue 928 944	Imposibilidad de
T66	Frequency 1025 1052	menos de 5 días a la semana
T69	LIVB 190 205	PERSONAL MEDICO
#54	AnnotatorNotes T69	C1704312; Health Professional; Professional or Occupational Group
T70	LIVB 485 504	Trabajador de salud
#55	AnnotatorNotes T70	C1704312; Health Professional; Professional or Occupational Group
T71	PHYS 577 585	embarazo
#56	AnnotatorNotes T71	C0032961; Pregnancy; Organism Function
T72	PHYS 1178 1186	visuales
#57	AnnotatorNotes T72	C0042789; Vision; Organism Function
T73	Date 150 164	PRE-EXPOSICIÓN
T55	Age 441 445	≥ 18
T56	Date 477 482	día 0
T59	Age 710 713	<18
T60	ANAT 1394 1404	glomerular
#58	AnnotatorNotes T60	C0022663; Kidney Glomerulus; Body Part, Organ, or Organ Component | C1284485; Entire glomerulus; Body Part, Organ, or Organ Component
A1	Assertion T71 Negated
A3	Assertion T16 Negated
A2	Status T33 History_of
A4	Status T50 History_of
A5	Status T19 History_of
#59	AnnotatorNotes T2	C5203670; COVID19 (disease); Disease or Syndrome
#60	AnnotatorNotes T6	C5203670; COVID19 (disease); Disease or Syndrome
#61	AnnotatorNotes T7	C0458074; Human immunodeficiency virus (HIV) status; Finding
#62	AnnotatorNotes T12	C5441447; Administration of anti-inflammatory agents; Therapeutic or Preventive Procedure 
T67	Observation 588 610	Voluntad de participar
T68	Observation 989 1013	participar en el estudio
A6	Assertion T68 Negated
#63	AnnotatorNotes T68	C1278516; Patient participation status; Finding
T74	Neg_cue 979 988	Rechazo a
#64	AnnotatorNotes T67	C0600109; Willing; Finding (?)
R1	Negation Arg1:T74 Arg2:T68	
R2	Before Arg1:T1 Arg2:T2	
R3	Causes Arg1:T53 Arg2:T2	
R4	Used_for Arg1:T3 Arg2:T1	
R5	Overlap Arg1:T40 Arg2:T73	
R6	Before Arg1:T40 Arg2:T25	
R7	Used_for Arg1:T4 Arg2:T40	
R8	Experiences Arg1:T69 Arg2:T40	
T75	Observation 209 220	ALTO RIESGO
#65	AnnotatorNotes T75	C4319571; High risk; Finding
R10	Experiences Arg1:T69 Arg2:T75	
R11	Overlap Arg1:T75 Arg2:T25	
R12	Causes Arg1:T54 Arg2:T6	
R13	Overlap Arg1:T41 Arg2:T56	
R14	Overlap Arg1:T8 Arg2:T56	
T76	Result_or_Value 464 473	negativas
#66	AnnotatorNotes T76	C0205160; Negative; Finding
R15	Has_Result_or_Value Arg1:T8 Arg2:T76	
R16	Has_Result_or_Value Arg1:T41 Arg2:T76	
R17	Experiences Arg1:T57 Arg2:T10	
R18	Negation Arg1:T58 Arg2:T71	
R19	Used_for Arg1:T42 Arg2:T11	
R20	Used_for Arg1:T43 Arg2:T12	
R21	Used_for Arg1:T44 Arg2:T13	
R22	Used_for Arg1:T14 Arg2:T13	
T77	Observation 851 866	Caso confirmado
#67	AnnotatorNotes T77	C4698719; Confirmed case; Finding
T78	Result_or_Value 901 909	positiva
#68	AnnotatorNotes T78	C1446409; Positive; Finding
R24	Has_Result_or_Value Arg1:T17 Arg2:T78	
R25	Causes Arg1:T64 Arg2:T78	
R26	Negation Arg1:T65 Arg2:T16	
T79	Result_or_Value 1212 1218	<50bpm
R29	Location_of Arg1:T46 Arg2:T24	
R30	Has_Result_or_Value Arg1:T23 Arg2:T79	
T80	Result_or_Value 1297 1300	> 5
R31	Has_Result_or_Value Arg1:T49 Arg2:T80	
R32	Has_Result_or_Value Arg1:T48 Arg2:T80	
T81	Result_or_Value 1274 1282	<3 mEq/L
R33	Has_Result_or_Value Arg1:T47 Arg2:T81	
R34	Location_of Arg1:T51 Arg2:T50	
R35	Location_of Arg1:T60 Arg2:T31	
T82	Result_or_Value 1405 1415	< 10ml/min
R36	Has_Result_or_Value Arg1:T31 Arg2:T82	
T83	Quantifier_or_Qualifier 1443 1449	severa
#69	AnnotatorNotes T83	C1547227; Severe - Severity of Illness Code; Intellectual Product
R37	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T83	
R38	Used_for Arg1:T35 Arg2:T34	
R39	Used_for Arg1:T36 Arg2:T34	
R40	Used_for Arg1:T37 Arg2:T34	
R41	Used_for Arg1:T38 Arg2:T34	
R42	Used_for Arg1:T39 Arg2:T34	
R43	Used_for Arg1:T27 Arg2:T34	
R44	Used_for Arg1:T32 Arg2:T34	
R45	Causes Arg1:T63 Arg2:T77	
R9	Experiences Arg1:T69 Arg2:T25	
R46	Overlap Arg1:T76 Arg2:T56	
R47	Experiences Arg1:T57 Arg2:T71	
T84	Observation 1016 1024;1053 1087	Trabajar en el Hospital Clinic of Barcelona
R23	Has_Frequency Arg1:T84 Arg2:T66	
A7	Experiencer T70 Patient
A8	Experiencer T57 Patient
A9	Experiencer T69 Patient
T85	Result_or_Value 551 560	Negativas
R27	Has_Result_or_Value Arg1:T10 Arg2:T85	
